PL410822A1 - Three-component combination to be used in the combined treatment of non-small-cell lung carcinoma - Google Patents
Three-component combination to be used in the combined treatment of non-small-cell lung carcinomaInfo
- Publication number
- PL410822A1 PL410822A1 PL410822A PL41082214A PL410822A1 PL 410822 A1 PL410822 A1 PL 410822A1 PL 410822 A PL410822 A PL 410822A PL 41082214 A PL41082214 A PL 41082214A PL 410822 A1 PL410822 A1 PL 410822A1
- Authority
- PL
- Poland
- Prior art keywords
- cell lung
- combined treatment
- small
- lung carcinoma
- component combination
- Prior art date
Links
- 208000002154 non-small cell lung carcinoma Diseases 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 239000000890 drug combination Substances 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 abstract 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 abstract 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 abstract 1
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem wynalazku jest trójskładnikowa kombinacja do zastosowania w leczeniu skojarzonym niedrobnokomórkowego raka płuca, w której włączenie analogu witaminy D do schematu leczenia opartego na skojarzeniu inhibitora kinaz tyrozynowych z cytostatykiem z grupy taksoidów nasila działanie przeciwnowotworowe kombinacji dwulekowej u chorych.The subject of the invention is a ternary combination for use in the combined treatment of non-small cell lung cancer, in which the inclusion of a vitamin D analogue in a treatment regimen based on the combination of a tyrosine kinase inhibitor with a taxoid cytostatic agent potentiates the antitumor effect of the drug combination in patients.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL410822A PL410822A1 (en) | 2014-12-30 | 2014-12-30 | Three-component combination to be used in the combined treatment of non-small-cell lung carcinoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL410822A PL410822A1 (en) | 2014-12-30 | 2014-12-30 | Three-component combination to be used in the combined treatment of non-small-cell lung carcinoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL410822A1 true PL410822A1 (en) | 2016-07-04 |
Family
ID=56234518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL410822A PL410822A1 (en) | 2014-12-30 | 2014-12-30 | Three-component combination to be used in the combined treatment of non-small-cell lung carcinoma |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL410822A1 (en) |
-
2014
- 2014-12-30 PL PL410822A patent/PL410822A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2015001985A1 (en) | Thiazolcarboxamides and pyridinecarboxamide compounds, pim kinase inhibitors. | |
| CY1122098T1 (en) | ISOCHROMENIUM DERIVATIVES AS PHOSPHOINOSITIDE-3 KINASE INHIBITORS | |
| CY1122247T1 (en) | CANCER INDUCTION USING PI3 KINASE ISOFORM MODIFIERS | |
| MX2021013837A (en) | APPROACH OF COMBINATION IMMUNOTHERAPIES FOR THE TREATMENT OF CANCER. | |
| ECSP17029203A (en) | KINASE INHIBITOR AURORA A | |
| MX2018001721A (en) | 5-BROMO-2,6-DI- (1H-PIRAZOL-1-IL) PIRIMIDIN-4-AMINA-FOR USE IN THE TREATMENT OF CANCER. | |
| MX383164B (en) | COMPOSITION CONTAINING RNA FOR THE TREATMENT OF TUMOR DISEASES. | |
| CO7350624A2 (en) | Bruton tyrosine kinase inhibitors | |
| MX2020011104A (en) | PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE. | |
| BR112016029041A8 (en) | use of a glutaminase inhibitor, pharmaceutical composition and pharmaceutical kit | |
| CL2016001604A1 (en) | "Compounds derived from pyrazolo [1,5-a] pyridine, axl and c-met kinase inhibitors; pharmaceutical composition comprising them; and its use in cancer treatment. ” pct | |
| DOP2015000108A (en) | PIRROLOPIRIMIDINE COMPOUNDS AS QUINASE INHIBITORS | |
| MX2020010412A (en) | Inhibitors of bruton's tyrosine kinase. | |
| CL2016000807A1 (en) | Amino heteroaryl benzamides as kinase inhibitors. | |
| MX378273B (en) | ACTIVE COMPOUNDS TOWARDS BROMODOMAINS. | |
| MX2016012097A (en) | Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer. | |
| ECSP17013903A (en) | PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE | |
| SV2018005687A (en) | DIHYDROIMIDAZOPIRAZINONA DERIVATIVES USED IN CANCER TREATMENT | |
| CL2014001865A1 (en) | Phosphate derived compounds; preparation procedure; pharmaceutical compositions containing them and use in the treatment of cancer. | |
| CL2016003214A1 (en) | Indolizine derivatives as phosphoinositide-3 kinase inhibitors | |
| MX2021014242A (en) | USE OF LINAGLIPTIN IN CARDIO- AND RENOPROTECTIVE ANTI-DIABETIC THERAPY. | |
| EA202090683A3 (en) | METHODS AND COMPOSITIONS FOR CANCER TREATMENT | |
| AR096892A1 (en) | A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA | |
| EA201892802A1 (en) | Derivatives of adenosine for use in the treatment of cancer | |
| MX380829B (en) | QUINOXALINE DERIVATIVES USEFUL AS FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) KINASE BUFFERERS. |